Active ingredientBrilacidinCat. No. P-B106-001CAS 1224095-98-0Family · Pharmaceutical analytical standards
Brilacidin
An investigational non-peptide antibacterial that mimics defensins, antimicrobial proteins of the innate immune system; developed by researchers at the University of Pennsylvania, it entered clinical trials in 2010 and has been tested for skin infections, oral mucositis and COVID-19. This family brings together the active ingredient.
Did you know?It kills bacteria by damaging their membrane; compounds of the same family have been proposed as additives for 'self-sterilising' paints, plastics and textiles.
Go to the active ingredient →Active ingredientBrilacidinCat. No. P-B106-001CAS 1224095-98-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.